Showing results (881-890 of 932) with videos related to
Sort By:
Pageof 94
Food and Nutrition Bulletin|October 31, 2013
Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countriesGerald T Keusch, Irwin H Rosenberg, Donna M Denno, et al.Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.Bioorganic & Medicinal Chemistry Letters|May 11, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studiesYunsong Tong, Akiyo Claiborne, Magdalena Pyzytulinska, et al.Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Isoquinoline-pyridine-based protein kinase B/Akt antagonists: SAR and in vivo antitumor activityGui-Dong Zhu, Jianchun Gong, Akiyo Claiborne, et al.Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancerQun Li, Keith W Woods, Sheela Thomas, et al.Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivativesStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potencyStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.Journal of Medicinal Chemistry|February 3, 2006
Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivoMichael D Wendt, Wang Shen, Aaron Kunzer, et al.Journal of Medicinal Chemistry|January 30, 2007
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xLMilan Bruncko, Thorsten K Oost, Barbara A Belli, et al.Journal of Medicinal Chemistry|July 31, 2007
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitorsLe Wang, Gerard M Sullivan, Laura A Hexamer, et al.Pageof 94